Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 67296-1077

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 67296-1077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure of orphenadrine citrate showing molecular formulas and atomic arrangements for both orphenadrine and citrate components. The molecular formula is C18H23NO·C6H8O7 with a molecular weight of 461.51.*

FDA Label Image

Image-02 (Image 02)

Orphenadrine Citrate Extended-Release Tablets, USP 100 mg oral tablets in a 100-count package. The label states prescription-only status and includes manufacturer Sandoz Inc. details along with storage instructions. The packaging features dosage, tablet image, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.